Research demonstrates drug efficacy in pediatric cancers using zebrafish, implying potential for precision therapy advancements.
Mouse and larval zebrafish PDX drug efficacy for responsive patients. A to D, Patient information, alongside mouse PDX waterfall plot of maximum tumor regression, and larval zebrafish tumor cell numbers for each therapy for Ewing sarcoma zccs505 (A), anaplastic large cell lymphoma zccs250 (B), neuroblastoma zccs51 (C), and Ewing sarcoma zccs59 (D). For mouse PDX data, colored columns represent individual mice. For larval zebrafish data, error bars represent mean ± SEM, each colored dot represents an individual larva, and a threshold is based on SEM of 1 dpi. Statistical analysis was conducted using a one-way ANOVA with the Dunnett multiple comparisons test, comparing the mean of each treatment group with control (4 dpi), P values: *, < 0.05; **, < 0.01; ***, < 0.001; ****, < 0.0001. Treatments are ordered and colored the same in mouse and zebrafish studies. mut, mutant; dpi, days post-injection.
No takes yet. Share an insight, caveat, or question.
Azzam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: